TR200200593T2 - Lakton içeren, yüksek molekül ağırlıklı bileşiklerin seperasyonuna yönelik metod. - Google Patents

Lakton içeren, yüksek molekül ağırlıklı bileşiklerin seperasyonuna yönelik metod.

Info

Publication number
TR200200593T2
TR200200593T2 TR2002/00593T TR200200593T TR200200593T2 TR 200200593 T2 TR200200593 T2 TR 200200593T2 TR 2002/00593 T TR2002/00593 T TR 2002/00593T TR 200200593 T TR200200593 T TR 200200593T TR 200200593 T2 TR200200593 T2 TR 200200593T2
Authority
TR
Turkey
Prior art keywords
separation
molecular weight
high molecular
mixture
adsorption
Prior art date
Application number
TR2002/00593T
Other languages
English (en)
Inventor
Higaki Tomoji
Yoshiyasu Takashi
Hasimoto Norihiro
Honda Keiji
Hatanaka Hiroshi
Yamashita Michio
Original Assignee
Fujisawa Pharmaceutical Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co., Ltd. filed Critical Fujisawa Pharmaceutical Co., Ltd.
Publication of TR200200593T2 publication Critical patent/TR200200593T2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/18—Bridged systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Epoxy Compounds (AREA)

Abstract

Lakton içeren, yüksek molekül agirlikli bir bilesigin separasyonuna yönelik bir metod olup, yan zincir olarak sayica düsük karbonlu bir alkenil grubu ve sayica düsük karbonlu bir alkoksi grubundan en az birisini ihtiva eden, lakton içeren yüksek molekül agirlikli bir bilesigin ve bunun analog bilesiginin/bilesiklerinin bir karisiminin bilesiklerin her birisinin separasyonu için asagida belirtilen etaplarin her hangi bir sirasi ile, ya bir etaba, yahut da iki etaba tabi tutulmasini içerir: karisimin non-iyonik bir adsorpsiyon reçinesine adsorpsiyonuna ve gümüs iyonlari içeren sulu bir solvenle elüsyona yönelik bir (A) etabi, ve karisiminin non-iyonik bir temelde aktif aluminaya adsorpsiyonuna ve organik bir solvenle elüsyona yönelik bir (B) etabi.
TR2002/00593T 1999-09-08 2000-09-05 Lakton içeren, yüksek molekül ağırlıklı bileşiklerin seperasyonuna yönelik metod. TR200200593T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP25381399 1999-09-08

Publications (1)

Publication Number Publication Date
TR200200593T2 true TR200200593T2 (tr) 2002-07-22

Family

ID=17256507

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2002/00593T TR200200593T2 (tr) 1999-09-08 2000-09-05 Lakton içeren, yüksek molekül ağırlıklı bileşiklerin seperasyonuna yönelik metod.

Country Status (23)

Country Link
US (2) US6576135B1 (tr)
EP (1) EP1210351B1 (tr)
JP (1) JP3925198B2 (tr)
CN (1) CN1195760C (tr)
AR (1) AR025598A1 (tr)
AT (1) ATE263773T1 (tr)
AU (1) AU779331B2 (tr)
BR (1) BR0014016B1 (tr)
CA (1) CA2384440C (tr)
CZ (1) CZ302625B6 (tr)
DE (1) DE60009723T2 (tr)
DK (1) DK1210351T3 (tr)
ES (1) ES2214307T3 (tr)
HU (1) HU230126B1 (tr)
MX (1) MXPA02002370A (tr)
NO (1) NO328422B1 (tr)
NZ (1) NZ517473A (tr)
PL (1) PL195650B1 (tr)
PT (1) PT1210351E (tr)
RU (1) RU2245338C2 (tr)
TR (1) TR200200593T2 (tr)
TW (1) TW553946B (tr)
WO (1) WO2001018007A2 (tr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW553946B (en) * 1999-09-08 2003-09-21 Fujisawa Pharmaceutical Co Method for separating lactone-containing high-molecular weight compounds
US7452692B2 (en) 2002-02-13 2008-11-18 Teva Gyógyszergyár Zártkörüen Müködö Részvénytársaság Method for extracting a macrolide from biomatter
MXPA04007847A (es) 2002-02-13 2005-02-24 Biogal Gyogyszergyar Metodo para extraer un macrolido de biomateria.
PL1558622T3 (pl) * 2003-07-24 2008-06-30 Teva Gyogyszergyar Zartkoerueen Muekoedoe Reszvenytarsasag Sposób oczyszczania makrolidów
EP1697383B1 (en) * 2003-12-05 2014-04-23 Biocon Limited Process for the purification of tacrolimus
DK1756290T3 (en) * 2004-04-12 2016-08-22 Biocon Ltd Streptomyces sp. BICC 7522 AND THE USE THEREOF FOR THE PRODUCTION OF MACRO-LIDER
US20080312447A1 (en) * 2004-09-10 2008-12-18 Ivax Pharmaceuticals S.R.O. Process for Isolation of Crystalline Tacrolimus
ITMI20042098A1 (it) * 2004-11-03 2005-02-03 Antibioticos Spa Processo per la purificazione di tacrolimus
CA2584430A1 (en) * 2004-12-01 2006-06-08 Teva Gyogyszergyar Zartkoruen Mukodo Reszvenytarsasag Methods for preparing pimecrolimus
CA2586692A1 (en) * 2004-12-22 2006-06-29 Teva Gyogyszergyar Zartkoruen Mukodo Reszvenytarsasag Method of purifying macrolides
JP2007527434A (ja) * 2005-01-05 2007-09-27 テバ ジョジセルジャール ザ−トケルエン ムケド レ−スベニュタ−ルシャシャ−グ 非晶質タクロリマス及びその調製
WO2007013017A1 (en) * 2005-07-29 2007-02-01 Ranbaxy Laboratories Limited A process for purification of macrolides
ITMI20051549A1 (it) * 2005-08-05 2007-02-06 Antibioticos Spa Purificazione del tacrolimus su supporti dimorigine vegetale
WO2007106587A2 (en) * 2006-03-15 2007-09-20 Teva Gyogyszergyar Zartköruen Muködo Reszvenytarsasag Process for purifying tacrolimus
US20080000834A1 (en) * 2006-03-15 2008-01-03 Ladislav Cvak Process for purifying Tacrolimus
US7952261B2 (en) * 2007-06-29 2011-05-31 Bayer Materialscience Ag Electroactive polymer transducers for sensory feedback applications
KR101022067B1 (ko) 2008-05-30 2011-03-17 이연제약주식회사 고순도 타크로리무스의 회수방법
KR100910165B1 (ko) 2008-09-18 2009-07-30 (주) 제노텍 은 이온 용액 추출을 이용한 불포화 알킬기를 가진 락톤 화합물 정제방법
WO2011163600A2 (en) 2010-06-25 2011-12-29 Apt Pharmaceuticals, Inc. Tacrolimus compositions for aerosol administration
EP2871188B1 (en) 2012-07-06 2017-04-19 Godo Shusei Co., Ltd. Method for separating cyclic macrolide compound
RU2694354C1 (ru) * 2018-09-25 2019-07-11 Закрытое акционерное общество "БиоХимМак СТ" Способ сорбционно-хроматографического выделения и очистки такролимуса

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8406218D0 (en) * 1984-03-09 1984-04-11 Glaxo Group Ltd Process
AU600187B2 (en) * 1987-12-15 1990-08-02 Unilever Plc Process for concentrating lactones, as well as the use of the concentrate thus obtained for flavouring foodstuffs
NO176766C (no) 1989-02-07 1995-05-24 Meiji Seika Kaisha Fremgangsmåte for fremstilling av en forbindelse med anthelmintaktivitet
JPH03191788A (ja) 1989-12-19 1991-08-21 Nippon Kayaku Co Ltd 新規抗生物質ｎｋ１５５１４１およびその製造法
TW553946B (en) * 1999-09-08 2003-09-21 Fujisawa Pharmaceutical Co Method for separating lactone-containing high-molecular weight compounds

Also Published As

Publication number Publication date
DE60009723T2 (de) 2005-04-28
CZ2002860A3 (cs) 2002-08-14
AR025598A1 (es) 2002-12-04
BR0014016A (pt) 2002-05-21
HUP0203196A2 (hu) 2002-12-28
DE60009723D1 (de) 2004-05-13
CN1373764A (zh) 2002-10-09
BR0014016B1 (pt) 2011-07-12
DK1210351T3 (da) 2004-08-02
RU2245338C2 (ru) 2005-01-27
NZ517473A (en) 2004-01-30
JP2003508536A (ja) 2003-03-04
CN1195760C (zh) 2005-04-06
NO328422B1 (no) 2010-02-15
CA2384440C (en) 2009-02-17
EP1210351B1 (en) 2004-04-07
MXPA02002370A (es) 2002-08-20
AU6871300A (en) 2001-04-10
AU779331B2 (en) 2005-01-20
CA2384440A1 (en) 2001-03-15
TW553946B (en) 2003-09-21
HK1048991A1 (en) 2003-04-25
PL353802A1 (en) 2003-12-01
PT1210351E (pt) 2004-08-31
EP1210351A2 (en) 2002-06-05
WO2001018007A3 (en) 2001-07-26
US20030168409A1 (en) 2003-09-11
US6576135B1 (en) 2003-06-10
HU230126B1 (hu) 2015-08-28
HUP0203196A3 (en) 2003-12-29
ATE263773T1 (de) 2004-04-15
ES2214307T3 (es) 2004-09-16
NO20021024L (no) 2002-05-02
NO20021024D0 (no) 2002-03-01
PL195650B1 (pl) 2007-10-31
WO2001018007A2 (en) 2001-03-15
US6881341B2 (en) 2005-04-19
CZ302625B6 (cs) 2011-08-10
JP3925198B2 (ja) 2007-06-06

Similar Documents

Publication Publication Date Title
TR200200593T2 (tr) Lakton içeren, yüksek molekül ağırlıklı bileşiklerin seperasyonuna yönelik metod.
TR199801587A2 (tr) Insülin öncü moleküllerinin elde edilmesine yönelik yöntem.
TR200000740T2 (tr) Dişleri beyazlatmak için metod ve kompozisyonlar.
BR0112693B1 (pt) (derivados) de Ácido sulfonilaminometilbenzàico substituÍdos, bem como processo para preparaÇço e uso dos mesmos.
HN1998000143A (es) Tetrahidronaftalenos substituidos y compuestos analogos.
BR9701462B1 (pt) hidroxifeniltriazinas, composiÇÕes, processo para estabilizar polÍmeros ou prÉ-polÍmeros orgÂnicos sintÉticos contra dano causado por luz, oxigÊnio e/ou calor, bem como uso dos referidos compostos.
WO2001064835A8 (en) Novel nucleic acids and polypeptides
BR9807502B1 (pt) compostos orgÂnicos, processo para sua preparaÇço, bem como composiÇço e aplicaÇço dos mesmos.
MXPA03004680A (es) Materiales antimicrobianos estabilizados con respecto a la luz.
CL2003002786A1 (es) Composicion liofilizada que comprende i) una epotilona y ii) manitol o una ciclodextrina y composicion liofilizada que los comprende reconstituida con solvente, util como citotoxico en el tratamiento de tumores.
ES2195970T3 (es) L-ribavirina y usos de la misma.
TR200001892T2 (tr) Monomer cinsi ensülin analogları ve bunların kullanımı.
BR9807843B1 (pt) heterociclos bicìclicos dissubstituìdos, composições farmacêuticas, uso, bem como processos para preparação das referidas composições e dos referidos compostos.
FR2715847B1 (fr) Composition contenant des acides nucléiques, préparation et utilisations.
ATE270298T1 (de) Reaktionssystem und verfahren zur verstärkung der lumineszenz von makrocyclischen lanthanid(iii)- komplexen
WO2001089571A3 (en) Method of increased bioavailability of nutrients and pharmaceutical preparations with tetrahydropiperine and its analogues and derivatives
FI964285A0 (fi) Taksaanien luokkaan kuuluviin johdannaisiin perustuvat farmaseuttiset valmisteet
WO2001064834A8 (en) Novel nucleic acids and polypeptides
BR0312814A (pt) Levamisol / avermectinas ou similares em solvente de pirrolidona
DE69813496D1 (de) Zyklodextrin-Zusammensetzung enthaltend ein Avermectin- oder ein Milbemycin-Derivat
BRPI0511802A (pt) processo para criação de meios para uso em separadores de ar/óleo
ES2154879T3 (es) Compuestos antiviricos.
ID28892A (id) Sintesa heteropoliasida
TR199902244T2 (tr) Taxan kombinasyonu ile birlikte dolastatin -15 türevleri.
ATE103485T1 (de) Haarbehandlungsmittel.